Cuatrecasas advised Deepull Diagnostics, S.L. on the deal.Deepull Diagnostics, S.L., (“Deepull”) completed a €50 million Series C funding round. Deepull, a medical diagnostics company developing culture-free…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
